Studies of the mechanisms of human B-cell activation. IV. Abnormalities at the B-cell level in patients with Behçet's disease
Suzuki, N.; Sakane, T.; Takada, S.; Ueda, Y.; Murakawa, Y.; Tsunematsu, T.; Tsuchiya, T.; Niwa, Y.
Ryumachi 25(2): 95-102
1985
ISSN/ISBN: 0300-9157 PMID: 3875902 Document Number: 244046
Document emailed within 1 workday
Related Documents
Pervin, K.; Childerstone, A.; Shinnick, T.; Mizushima, Y.; van der Zee, R.; Hasan, A.; Vaughan, R.; Lehner, T. 1993: T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease Journal of Immunology 151(4): 2273-2282Accardo-Palumbo, A.; Ferrante, A.; Cadelo, M.; Ciccia, F.; Parrinello, G.; Lipari, L.; Giardina, A.R.; Riili, M.; Giardina, E.; Dieli, F.; Triolo, G. 2004: The level of soluble Granzyme a is elevated in the plasma and in the Vgamma9/Vdelta2 T cell culture supernatants of patients with active Behçet's disease Clinical and Experimental Rheumatology 22(4 Suppl 34: S45-S49
Fattorossi, A.; Matricardi, P.M.; Pizzolo, J.G.; Le Moli, S.; Antonelli, G.; D'Amelio, R. 1991: Lack of specificity in the mechanisms involved in the enhancement of the concanavalin A driven human T lymphocyte stimulation by beta-endorphin: studies on activation marker expression, cell cycle and interleukin release Journal of Biological Regulators and Homeostatic Agents 5(3): 91-97
Lim, S.D.; Haw, C.R.; Kim, N.I.; Fusaro, R.M. 1983: Abnormalities of T-cell subsets in Behçet's syndrome Archives of Dermatology 119(4): 307-310
Kibaroglu, A.; Eksioglu-Demiralp, E.; Akoglu, T.; Direskeneli, H. 2004: T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Behçet's disease Clinical and Experimental Rheumatology 22(4 Suppl 34: S59-S63
Francis, M.L.; Moss, J.; Fitz, T.A.; Mond, J.J. 1990: CAMP-independent effects of cholera toxin on B cell activation. I. a possible role for cell surface ganglioside GM1 in B cell activation Journal of Immunology 145(10): 3162-3169
Van der Loo, W.; Gronowicz, E.S.; Strober, S.; Herzenberg, L.A. 1979: Cell differentiation in the presence of cytochalasin B: studies on the "switch" to IgG secretion after polyclonal B cell activation Journal of Immunology 122(4): 1203-1208
Shlapatska, L.M.; Kovalevska, L.M.; Gordiienko, I.M.; Sidorenko, S.P. 2014: Intrinsic defect in B-lymphoblastoid cell lines from patients with X-linked lymphoproliferative disease type 1. I. Cell surface phenotype and functional studies Experimental Oncology 36(1): 2-8
Direskeneli, H.; Ekşioglu-Demiralp, E.; Yavuz, S.; Ergun, T.; Shinnick, T.; Lehner, T.; Akoglu, T. 2000: T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease Journal of Rheumatology 27(3): 708-713
Pezzutto, A.; Dörken, B.; Moldenhauer, G.; Clark, E.A. 1987: Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140 Journal of Immunology 138(1): 98-103
Chartash, E.K.; Imai, A.; Gershengorn, M.C.; Crow, M.K.; Friedman, S.M. 1988: Direct human T helper cell-induced B cell activation is not mediated by inositol lipid hydrolysis Journal of Immunology 140(6): 1974-1981
Tseng, C.T.; Springgate, C.F.; Tadmori, W.; Choi, Y.S. 1988: Identification of a novel human B cell activation antigen involved in B cell growth factor-dependent proliferation Journal of Immunology 140(7): 2305-2311
Kikutani, H.; Nakamura, H.; Sato, R.; Kimura, R.; Yamasaki, K.; Hardy, R.R.; Kishimoto, T. 1986: Delineation and characterization of human B cell subpopulations at various stages of activation by using a B cell-specific monoclonal antibody Journal of Immunology 136(11): 4027-4034
Rubin, P.; Pross, H.F.; Roder, J.C. 1982: Studies of human natural killer cells. II. Analysis at the single cell level Journal of Immunology 128(6): 2553-2558
Chirmule, N.; Kalyanaraman, V.S.; Lederman, S.; Oyaizu, N.; Yagura, H.; Yellin, M.J.; Chess, L.; Pahwa, S. 1993: HIV-gp 160-induced T cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6 Journal of Immunology 150(6): 2478-2486
Bennett, J.S.; Tredway, T.L.; Dizikes, G.J.; Nawrocki, J.F. 1994: Properties of a novel gene isolated from a Hodgkin's disease cell line that is expressed early during lymphoid cell activation Journal of Immunology 152(5): 2229-2240
Berman, E.; Rubin, B.Y.; Broxmeyer, H.E. 1986: Regulation of the proliferation of the established human monoblast cell line, U937, at the single cell level Cancer Research 46(7): 3309-3312
Bradley, T.P.; Bonavida, B. 1982: Mechanism of cell-mediated cytotoxicity at the single cell level. IV. Natural killing and antibody-dependent cellular cytotoxicity can be mediated by the same human effector cell as determined by the two-target conjugate assay Journal of Immunology 129(5): 2260-2265
Schulz, S.; Klann, R.C.; Schönfeld, S.; Nyce, J.W. 1992: Mechanisms of cell growth inhibition and cell cycle arrest in human colonic adenocarcinoma cells by dehydroepiandrosterone: role of isoprenoid biosynthesis Cancer Research 52(5): 1372-1376
Verhasselt, V.; Vanden Berghe, W.; Vanderheyde, N.; Willems, F.; Haegeman, G.; Goldman, M. 1999: N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition Journal of Immunology 162(5): 2569-2574